---
title: Broadly neutralizing antibodies isolated from HEV convalescents confer protective
  effects in human liver-chimeric mice
date: '2025-02-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/40011441/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250227170943&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Hepatitis E virus (HEV) causes 3.3 million symptomatic cases and 44,000
  deaths per year. Chronic infections can arise in immunocompromised individuals,
  and pregnant women may suffer from fulminant disease as a consequence of HEV infection.
  Despite these important implications for public health, no specific antiviral treatment
  has been approved to date. Here, we report combined functional, biochemical, and
  X-ray crystallographic studies that characterize the human antibody response ...
disable_comments: true
---
Hepatitis E virus (HEV) causes 3.3 million symptomatic cases and 44,000 deaths per year. Chronic infections can arise in immunocompromised individuals, and pregnant women may suffer from fulminant disease as a consequence of HEV infection. Despite these important implications for public health, no specific antiviral treatment has been approved to date. Here, we report combined functional, biochemical, and X-ray crystallographic studies that characterize the human antibody response ...